Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Kedudukan dalam Saham #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Harga Saham
$1.05
Disegerakkan terakhir: 2026-08-19
Modal Pasaran
$25.12M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-86.33%
Negara
US
Perdagangan Actuate Therapeutics Inc (ACTU)

Kategori

Nisbah P/B bagi Actuate Therapeutics Inc (ACTU)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Actuate Therapeutics Inc, nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Actuate Therapeutics Inc dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH